No Recurrence of VTE 1 Year after COVID-19-Associated VTE Event
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
In patients with sepsis and atrial fibrillation, how does treatment with phenylephrine vs norepinephrine affect heart rate?
Investigators examined in-hospital mortality in patients hospitalized with COVID-19 with new-onset atrial arrhythmias and history of atrial arrhythmias.
Investigators examined the prevalence, clinical impact, and associations of pericardial involvement in patients hospitalized for treatment for COVID-19.
Some previous or preexisting cardiovascular conditions are associated with increased severity of COVID-19 among children.
Hispanic patients presenting to the emergency department with chest pain wait longer to be treated, admitted, or discharged.
The risk for myocarditis and pericarditis after COVID-19 mRNA vaccines is highest in young men after the second vaccine dose.
Researchers conducted a study to determine risk factors associated with incident atrial fibrillation in patients with HIV infection.
To what extent is heart failure appropriately diagnosed and treated among patients hospitalized with COPD exacerbations, who are known to be at risk for HF?
For patients with established atherosclerotic cardiovascular disease, the treatment benefit of smoking cessation is equivalent to the use of targeted pharmaceutical interventions in persistent smokers.